(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC

Clinical trial NCT05153408 · TERMINATED

Trial details

NCT number: NCT05153408
Sponsor: Blueprint Medicines Corporation
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Neoplasm Carcinoma, Non-Small-Cell Lung Respiratory Tract Neoplasms Neoplasms Neoplasms by Site Lung Diseases Respiratory Tract Diseases Carcinoma, Bronchogenic Bronchial Neoplasms Adenocarcinoma Carcinoma Neoplasms by Histologic Type

Start date: 2022-01-13
Primary completion: 2022-12-09
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.